Fundraising FoxLongwood Fund — 2014 Investments
1 investments dated 2014 · listed companies and verified rows first · show all
Calithera BiosciencesinJul 2014Defunct
Calithera Biosciences was a clinical-stage biopharmaceutical company developing small-molecule oncology drugs targeting tumor metabolism, including the glutaminase inhibitor telaglenastat.
BiotechSouth San Francisco, US
Susan M. Molineaux(Executive Officer, Director)inWilliam Waddill(Executive Officer)in
BoardJean M. George(Director)Deepa Pakianathan(Director)inRalph E. Christoffersen(Director)Jonathan Drachman(Director)
Co-investorsVenture Capital Investment ManagementThe Column Group
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.